Related Experiment Videos

The role of A beta 42 in Alzheimer's disease

S G Younkin1

  • 1Mayo Clinic Jacksonville, Florida 32224, USA.

Insights

Familial Alzheimer's disease (FAD) mutations increase extracellular beta-amyloid 42 (A beta 42), a key factor in Alzheimer's disease (AD) pathogenesis. This finding supports the hypothesis that A beta deposition is an early event in all forms of AD.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Familial Alzheimer's disease (FAD) is linked to specific genetic mutations.
  • Amyloid beta (A beta) deposition in senile plaques is a hallmark of Alzheimer's disease (AD).

Purpose of the Study:

  • To investigate the fundamental effect of FAD-linked mutations.
  • To determine the relationship between FAD mutations, A beta 42 levels, and AD pathogenesis.

Main Methods:

  • Studies conducted on plasma, fibroblasts, transfected cells, and transgenic mice.
  • Analysis of extracellular A beta 42 concentrations.

Main Results:

  • FAD-linked mutations fundamentally increase extracellular A beta 42 concentration.
  • Elevated A beta 42 correlates with early and selective deposition in senile plaques.
  • This mechanism is proposed to be directly related to AD pathogenesis.

Conclusions:

  • FAD mutations cause AD by increasing extracellular A beta 42, promoting deposition.
  • Cerebral A beta deposition is an essential early event in the pathogenesis of all AD forms.
  • Potential interactions between the basal forebrain cholinergic system and A beta in AD pathogenesis are discussed.

Related Concept Videos